Virbac
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Dec 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 12, 2027The maintenance fee for Methods and Compositions for Treatment of Anxiety in Animals (US 11,752,127) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
- 1 fee due Apr 1, 2027The maintenance fee for Oil suspension of metronidazole (US 10,426,840) comes due Apr 1, 2027. Unpaid by Oct 1, 2027, it lapses early.
- 1 fee due May 21, 2027The maintenance fee for Novel Use of Glucocorticoids for the Treatment of Epithelial Microbial Infections of a Fluid Containing Organ with a Natural Exterior Orifice in Mammals (US 11,819,506) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
- 1 fee due Jun 3, 2027The maintenance fee for Nutritional and medicinal oral composition for veterinary use (US 10,493,032) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.
- 1 fee due Aug 4, 2027The maintenance fee for Soothing composition for animals, comprising at least one fatty acid and nepetalactone (US 10,548,867) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,197,839 | Sustained release delivery system In force · From the USPTO record | In force | From the USPTO record | |
| US 9,944,604 | Aminobenzamide Derivatives as Useful Agents for Controlling Animal Parasites In force · Medium confidence | In force | Medium confidence | |
| US 9,681,642 | Edible, chewable object for carnivorous pets and method of controlling the hygiene of the oral cavity of said pets using one such object In force · From the USPTO record | In force | From the USPTO record | |
| US 10,426,840 | Oil suspension of metronidazole In force · From the USPTO record | In force | From the USPTO record | |
| US 10,166,186 | Nutritional and medicinal oral composition for veterinary use In force · From the USPTO record | In force | From the USPTO record | |
| US 10,493,032 | Nutritional and medicinal oral composition for veterinary use In force · From the USPTO record | In force | From the USPTO record | |
| US 9,974,736 | Veterinary pharmaceutical compositions and method for the production thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,149,895 | Composition for the treatment of progressive renal diseases In force · From the USPTO record | In force | From the USPTO record | |
| US 10,071,102 | Injectable mirtazapine for treating appetite loss and nutritional disorders in cats In force · From the USPTO record | In force | From the USPTO record | |
| US 10,300,012 | Topical Composition Comprising Extracts of Boldo and of Meadowsweet, Intended for an Animal, and Uses Thereof In force · High confidence | In force | High confidence |
Also on record, not counted in the 26: 10 lapsed for an unpaid fee · 19 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 10 no status recorded